<DOC>
	<DOCNO>NCT00693927</DOCNO>
	<brief_summary>Prospective randomize study allogeneic minitransplantation HLA-identical family unrelated donor compare unmanipulated CD8-depleted PBSC . The condition regimen 2 Gy TBI alone ( related donor low-risk transplant rejection ) 2 Gy TBI 3 x 30 mg/m2 fludarabine ( unrelated donor high risk transplant rejection ) . Patients receive short intensive immunosuppressive treatment ( cyclosporine mycophenolate mofetil ) ensure graft-versus-host host-versus-graft tolerance . The rationale use PBSC instead marrow transplant avoid general anesthesia donor minimize risk rejection . The rationale CD8+ depletion diminish risk GVHD PBSC transplantation DLI .</brief_summary>
	<brief_title>Nonmyeloablative Stem Cell Transplantation With CD8-depleted Unmanipulated Peripheral Blood Stem Cells ( PBSC )</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<criteria>1 . Patients 1.1 . Diseases Malignant disease confirm histologically rapidly progress : Hematologic malignancy AML ; ALL ; CML myeloproliferative disorder ; MDS ; Multiple myeloma ; CLL ; NonHodgkin 's lymphoma ; Hodgkin 's disease . Nonhematologic malignancies Renal cell carcinoma ( metastatic ) . 1.2 . Inclusion criterion Male female ; female patient must use reliable contraception method ; Age low 70 yr ( family donor ) low 65 yr ( unrelated donor ) ; HIV negative ; No terminal organ failure ; No uncontrolled infection , arrhythmia hypertension ; Family donor ( HLAidentical ) unrelated donor ( match AB low resolution type DRB1DQB1 high resolution type ) ; No previous radiation therapy precluding use 2 Gy TBI Informed consent give patient his/her guardian minor age . 1.3 . Clinical situation Theoretical disease indication standard allotransplant , feasible : Age &gt; 55 yr ; Unacceptable end organ performance ; Patient 's refusal . Indication standard autotransplant : perform miniallotransplantation 26 month standard autotransplant . Not indication intensification potential candidate cellular immunotherapy . 2 . Donors 2.1 . Inclusion criterion Related recipient ( sibling , parent child ) unrelated ; Male female ; Weight &gt; 15 Kg ( leukapheresis ) ; HIV negative ; No major contraindication allogeneic PBSC donation generally accept criterion ; Informed consent give donor his/her guardian minor age . 2.2 . Exclusion criterion Any condition fulfil inclusion criterion ; Unable undergo leukapheresis poor vein access reason .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Hematopoietic cell transplantation</keyword>
	<keyword>Allogeneic</keyword>
	<keyword>Nonmyeloablative</keyword>
	<keyword>CD8-depletion</keyword>
	<keyword>PBSC</keyword>
	<keyword>GVHD</keyword>
	<keyword>Hematological malignancy renal cell carcinoma</keyword>
</DOC>